AB

Abivax S.A.

  • CIK: 0001956827
  • EIN: 00-0000000
  • Business address: 7 BD HAUSSMANN, PARIS, France, 75009

Information

  • Mailing address
    7 BD HAUSSMANN, PARIS, France, 75009
  • Phone
    01 53 83 09 63
  • State location
    France
  • State of incorporation
    France
  • Fiscal year end
    December 31
  • SIC
    2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
  • Filings
    N/A

About Abivax S.A.

Abivax S.A. (CIK: 0001956827) is an American company incorporated in the state of France. Head office is located at 7 BD HAUSSMANN, PARIS, France, 75009. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. Abivax S.A. is a public company and trade via Over-The-Counter (OTC).

Ownership

Updating!

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Abivax S.A.

Filings Format Description Filed/Effective File/Film Number
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-005129 (34 Act) Size: KB		 Sep-09-2024

001-41842

241287553
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001956827-24-000013 (34 Act) Size: KB		 Sep-09-2024

001-41842

241287276
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-004450 (34 Act) Size: KB		 Aug-06-2024

001-41842

241176904
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-003960 (34 Act) Size: KB		 Jul-16-2024

001-41842

241118527
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001193125-24-154293 (34 Act) Size: KB		 Jun-04-2024

001-41842

241018500
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-002617 (34 Act) Size: KB		 May-07-2024

001-41842

24922408
SC 13G Document

Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0001193125-24-103197 (34 Act) Size: KB		 Apr-19-2024

005-94198

24859241
20-F Document

Annual and transition report of foreign private issuers pursuant to sections 13 or 15(d)

Acc-no: 0001956827-24-000007 (34 Act) Size: KB		 Apr-05-2024

001-41842

24826435
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-001756 (34 Act) Size: KB		 Apr-02-2024

001-41842

24812568
SC 13G/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0001104659-24-024198 (34 Act) Size: KB		 Feb-14-2024

005-94198

24641639
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-000531 (34 Act) Size: KB		 Feb-02-2024

001-41842

24588700
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-000324 (34 Act) Size: KB		 Jan-22-2024

001-41842

24547036
SC 13G Document

Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0001104659-23-120756 (34 Act) Size: KB		 Nov-22-2023

005-94198

231433697
SC 13G Document

Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0001172661-23-003538 (34 Act) Size: KB		 Oct-30-2023

005-94198

231360362
SC 13D Document

Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities

Acc-no: 0001104659-23-112496 (34 Act) Size: KB		 Oct-30-2023

005-94198

231359397
424B4 Document

Prospectus filed pursuant to Rule 424(b)(4)

Acc-no: 0001193125-23-260833 (33 Act) Size: KB		 Oct-23-2023

333-274780

231340208
SEC STAFF LETTER Document Acc-no: 9999999997-23-004568 ( Act) Size: KB Oct-20-2023

FWP Document

Filing under Securities Act Rules 163/433 of free writing prospectuses

Acc-no: 0001193125-23-259657 (34 Act) Size: KB		 Oct-20-2023

333-274780

231336046
EFFECT Document Acc-no: 9999999995-23-003017 (33 Act) Size: KB Oct-19-2023

333-274845

231335892
EFFECT Document Acc-no: 9999999995-23-003016 (33 Act) Size: KB Oct-19-2023

333-274780

231335887

Recent 20 filings. View all Abivax S.A. filings

Reviews

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Frequently Asked Questions

Tags:

  • Abivax S.A. overview
  • Abivax S.A. job
  • Abivax S.A. stock
  • Abivax S.A. ownership
  • Abivax S.A. CEO
  • Abivax S.A. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Metsera, Inc.
Update: Nov 21, 2024
Curanex Pharmaceuticals Inc
Update: Oct 17, 2024
Apimeds Pharmaceuticals US, Inc.
Update: Sep 26, 2024
Upstream Bio, Inc.
Update: Sep 19, 2024
Bicara Therapeutics Inc.
Update: Aug 23, 2024
Stramsen Biotech, Inc.
Update: May 21, 2024

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 1646 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 3868 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 4702 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 3273 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 3145 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 2724 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 1616 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 2873 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 1916 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by